Specifically, almost all malignant rhabdoid tumors (MRTs) and ATRTs, which are highly aggressive childhood cancers without effective therapy, contain biallelic inactivating mutations in the SMARCB1 (SNF5, INI1, BAF47) subunit2,3. The gene discussed is SMARCB1; the disease is rhabdoid tumor.